1.22
+0(+0.00%)
Currency In USD
| Previous Close | 1.22 |
| Open | 1.21 |
| Day High | 1.22 |
| Day Low | 1.2 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.13 |
| Volume | 24,908 |
| Average Volume | 44,207 |
| Market Cap | 59.84M |
| PE | -4.88 |
| EPS | -0.25 |
| Moving Average 50 Days | 1.27 |
| Moving Average 200 Days | 1.45 |
| Change | 0 |
If you invested $1000 in MediciNova, Inc. (MNOV) 10 years ago, it would be worth $423.61 as of October 24, 2025 at a share price of $1.22. Whereas If you bought $1000 worth of MediciNova, Inc. (MNOV) shares 5 years ago, it would be worth $221.82 as of October 24, 2025 at a share price of $1.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
GlobeNewswire Inc.
Oct 06, 2025 12:00 PM GMT
LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces t
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
~Patient Recruitment Closed~LA JOLLA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875),
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
GlobeNewswire Inc.
Sep 16, 2025 12:00 PM GMT
LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abs